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INTRODUCTION
The use of mushrooms as therapeutics dates back to over 2000 years ago, including the use of Laricifomes officinalis in Europe and Ganoderma lingzhi in China. Fruitbodies of Piptoporus betulinus ( Figure 1G ) found among the items of "Ötzi the Iceman", a 5000-year-old European mummy, were presumably used as a remedy against parasitic worms [1] . The traditional usage of mushrooms in European folk medicine, e.g. of "Judas' Ear", Auricularia auricula-judae ( Figure   1B ) gradually disappeared in the 18 th and 19 th centuries [2] . Trametes versicolor ( Figure 1I ). In the West, mushrooms were used only for ornamental purposes, as opposed to the East where they were used as medicine. However, in comparison to the uninterrupted development and cultivation in East Asia for many centuries, the medical research and usage of mushrooms has experienced a relatively recent revival and development in Western countries. In traditional Chinese medicine and folk medicines, mushrooms have not been used specifically to treat cancer, but have been used for general disease prevention or to treat other diseases. For example, one of the most commonly used medical fungi in Chinese medicine is Wolfiporia cocos ("fu ling"). The antitumor properties of medical fungi were discovered mostly through screening them with modern scientific methods.
In contrast to other diseases traditionally treated with medical mushrooms, there is little data for mushrooms and the treatment of cancer. Consequently, this may explain why few mushroombased anticancer therapeutics are available.
Nonetheless, scientific research devoted to anticancer properties of mushrooms started worldwide in the 1960s [2] . In this review, the recent development of a mushroom from Taiwan was examined to illustrate the process from ethnomedicine to new, science-based anticancer therapeutics. 
HISTORY AND TRADITIONAL APPLICATION
Taiwanofungus camphoratus is the most studied species of all the fungi with anti-cancer potential activity. Over 900 related scientific research reports have been published in international journals on the anti-cancer potential of T. camphoratus . The following text analyzes T. camphoratus as an example of a medical fungus to illustrate the general process from ethnomedicine to developing new products for the market based on scientific, analytical and experimental evidence.
Antrodia cinnamomea, also known as Antrodia camphorata or Taiwanofungus camphoratus, is a precious and unique edible fungus that grows naturally only on the aromatic tree Cinnamomum kanehirae (Lauraceae; Figure 2 ), which is native to Taiwan [3, 4] . Wild T. camphoratus grows between June and October at altitudes between 600 and 1800 m. The mushroom prefers to grow on the inner wall inside cavities of old tree trunks. Some fruit bodies grow on moist surfaces of dead trees or on the stumps of cut trees. The growth rate of wild T. camphoratus mushroom is extremely slow. A ten year old fruit body has a dimension of only 25x15x12 mm. The scarcity of the natural host and slow growth rate of the mushroom rendered this treasured mushroom as "ruby in Taiwanese forests".
T. camphoratus has been used medically by aboriginal tribes for centuries to treat diseases like food and drug intoxication, diarrhea, abdominal pain, hypertension, skin itching, and cancer [5] . The earliest record of a medical recipe against intoxication using T. camphoratus was given by the traditional Chinese medicine doctor Tsai in 1983 with the formula of the recipe reported in 1987 [6] . Scientific study of T. camphoratus started in 1990 and the first reports of its biological functions have been documented in National Digital Library of Theses and Dissertations in Taiwan [7] . Over the past decade, more than 300 papers and 150 Taiwan patent applications for T. camphoratus have been documented [8, 9] . Numerous studies have been conducted on its physiology, biological, and pharmacological properties. Genomic and transcriptomic analyses of the medicinal fungus T. camphoratus have been reported [10] . A 32.15-Mb genome draft containing 9,254 genes was cloned and genome ontology enrichment and pathway analyses were studied to uncover the sexual development and the biosynthesis of sesquiterpenoids, triterpenoids, ergostanes, antroquinonol, and antrocamphin. 
Human estrogen-non-responsive breast cancer (MDA-MB-231) cells [11] Non-cytotoxic concentrations (20-80 µg/mL) of extract can inhibit the invasion/migration of highly metastatic MDA-MB-231 cells through suppression of the MAPK signaling pathway.
Pancreatic cancer (PANC-1 and
AsPC-1) cells [12] Antroquinonol can induce G1 arrest of the cell cycle and a following apoptosis in human pancreatic cancers through an inhibitory effect on PI3-kinase/Akt/mTOR pathways that in turn down-regulates cell cycle regulators.
AsPC-1) cells [12] Antroquinonol also can induce the connection between apoptosis, autophagic cell death and accelerated senescence in Oral cancer (OECM1 and OC-2)
cell lines [16] The mechanism of growth inhibition was apoptosis induction, resultant of caspase-3 activation and DNA fragmentation. The immune systems can be classified into the innate immune system (i.e. non-specific immune system or in-born immunity system), and adaptive immune system (also known as the acquired immune system or the specific immune system). The innate immune system is made up of cells and mechanisms that defend the host from infection by other organisms. The cells of the innate system recognize and respond to pathogens in a general way. The adaptive immune system is composed of highly specialized cells and processes to eliminate pathogens or prevent their growth. Natural killer (NK) cells hold an important role in immunity and chemo-preventive activity in human beings. They are crucial in innate immunity capturing viruses and killing cancer cells,as well as participating in adaptive immunity. The innate immune system provides immediate defense against infection by: 1) recruiting immune cells to sites of infection through the production of chemical factors called cytokines; 2)
activating the complement cascade to identify bacteria, activate cells, and promote clearance of antibody complexes or dead cells; 3) identifying and removing foreign substances present in organs, tissues, blood and lymph, by specialized white blood cells; 4) activating the adaptive immune system through a process known as antigen presentation; 5) acting as a physical and chemical barrier to infectious agents. The adaptive immunity creates an immunological memory after an initial response to a specific pathogen, and leads to an enhanced response to subsequent encounters with that pathogen.
This process of acquired immunity is the basis of vaccination. Like the innate system, the adaptive system includes both humoral immunity components and cell-mediated immunity components.
Some of these compounds are responsible for the stimulation of the immune system in a way that is shared by many medical mushrooms [18] , while other compounds appear to be more specific to T. camphoratus and show specific cytotoxic activity against cancer cells. Many biologically active compounds have been isolated from T. camphoratus and some of the structures have been determined [19, 20] . The most widely studied components among the numerous isolated compounds of T. camphoratus are: 1) antroquinonol and its derivatives; 2) succinic and maleic acid derivatives; 3) triterpenoids; 4) benzenoids; 5) polysaccharides; and 6) volatile essential oils.
Both polysaccharides and volatile essential oils have low cytotoxic activity against normal and cancerous cells. They can activate all the cells of the innate immune system, such as NK cells, and of the adaptive immune system, such as B cells. [21, 22] .
APPLICATION AND GLOBAL MARKETING
Although the detailed procedure of manufacturing T. camphoratus for the market is the secret of companies, some basic information is presented (Figure 7 ). Fruitbodies collected in hollows of wild old trees of Cinnamomum kanehirae are considered the best for accompanying anticancer treatment. However, due to exorbitant prices and concerns of nature conservation the second choice of using fruitbodies from artificial cultivation on wood logs from plantations of C.
kanehirae is an adequate alternative. Mycelia grown on wood logs or artificial solid substrates are considered the third choice. Mycelia grown in liquid culture are cheaper, particularly when they are not separated from the cultivation medium. Mycelia are less recommended for usage against cancer, but can be utilized in the treatment of less severe diseases and as health food.
Fruitbodies (or mycelia) are frozen or dried and can be extracted with hot water or organic solvents (alcohol) for direct uptake. In order to ensure standardized amounts, dried fruitbodies or mycelia are also powdered to be made into pressed tablets or filled into capsules, or their liquid extract is filled into small vials. Extracts provide the advantage that their compounds can be enriched by concentration and used conveniently as liquid or after spraying the highly concentrated extracts onto globuli also in solid form. Taiwanofungus camphoratus (synonym Antrodia cinnamomea) is an endemic polypore with red fruitbodies that is only formed on a tree of the laurel family also endemic to Taiwan. The fungus has commonly been used in ethnomedicine. Fruitbodies of T. camphoratus have the best effect while mycelium from liquid culture has the weakest effect.
Among the main groups of anticancer compounds of T. camphoratus γ-dodecalactone (γ-DDL) and polysaccharides are mainly responsible for immunomodulatory effects, whereas cytotoxic effects are exerted by derivatives of antroquinonol as well as succinic and maleic acid, triterpenoids, and benzenoids. The triterpenoids are particularly highly specific for T. camphoratus and rich with respect to concentration and structural diversity.
T. camphoratus and other medicinal mushrooms play an increasing role in anticancer treatment and in the global market.
